Zobrazeno 1 - 10
of 20
pro vyhledávání: '"John R. Jalas"'
Autor:
Javier I. J. Orozco, Theo A. Knijnenburg, Ayla O. Manughian-Peter, Matthew P. Salomon, Garni Barkhoudarian, John R. Jalas, James S. Wilmott, Parvinder Hothi, Xiaowen Wang, Yuki Takasumi, Michael E. Buckland, John F. Thompson, Georgina V. Long, Charles S. Cobbs, Ilya Shmulevich, Daniel F. Kelly, Richard A. Scolyer, Dave S. B. Hoon, Diego M. Marzese
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-14 (2018)
The treatment of brain metastases is often limited by the ability to diagnose their origins. Here the authors generate DNA methylomes from the three most frequent types of brain metastases, identify epigenetic signatures specific to each type of meta
Externí odkaz:
https://doaj.org/article/48d7f470aacb41c6b7ae96cfd0196169
Autor:
John R. Jalas, Diego M. Marzese, Miquel Ensenyat-Mendez, Matthew P. Salomon, Ayla O. Manughian-Peter, Javier I. J. Orozco, Maggie L. DiNome, Shu-Ching Chang, Chikako Matsuba
Publikováno v:
Annals of Surgical Oncology. 26:3344-3353
Triple-negative breast cancer (TNBC) is a heterogeneous collection of breast tumors with numerous differences including morphological characteristics, genetic makeup, immune-cell infiltration, and response to systemic therapy. DNA methylation profili
Autor:
James S. Wilmott, Ayla O. Manughian-Peter, Diego M. Marzese, Yuki Takasumi, Daniel F. Kelly, Ilya Shmulevich, Matthew P. Salomon, John R. Jalas, Javier I. J. Orozco, Garni Barkhoudarian, Dave S.B. Hoon, Xiaowen Wang, John F. Thompson, Charles Cobbs, Georgina V. Long, Theo A. Knijnenburg, Richard A. Scolyer, Michael E. Buckland, Parvinder Hothi
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-14 (2018)
Nature Communications
Nature Communications
Optimal treatment of brain metastases is often hindered by limitations in diagnostic capabilities. To meet this challenge, here we profile DNA methylomes of the three most frequent types of brain metastases: melanoma, breast, and lung cancers (n = 96
Autor:
Shu-Ching Chang, John R. Jalas, Dany K Barrak, Anton J. Bilchik, Abhineet Uppal, Ahmed Dehal, Yalda Naeini
Publikováno v:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 24(1)
Expression of CD3+ T cells, CD8+ cytotoxic T cells, CD45RO+ memory T cells, and FOXP3+ regulatory T cells at the invasive margin (IM) and tumor center (TC) has correlated with survival in gastric adenocarcinoma (GA) patients from East Asia, independe
Autor:
Darryl Nousome, John R. Jalas, Rebecca Gentry, David L. Krasne, Matthew P. Salomon, Timothy Wilson, Dave S.B. Hoon, Ramkishen Narayanan, Jennifer Linehan, Kevin N. Tran
Publikováno v:
Journal of Urology. 201
Autor:
Devin C. Flaherty, Myung Sim, John R. Jalas, Alexander Stojadinovic, Anton J. Bilchik, Mladjan Protic, Delphine J. Lee
Publikováno v:
Annals of surgical oncology. 25(5)
The association between tumor mismatch repair status and obesity in colon cancer is not well understood. The authors of this study hypothesized that mismatch repair deficiency in colon cancer may be associated with a lower Body Mass Index (BMI) and i
Publikováno v:
Gastroenterology. 156:S-1424
Autor:
Ricardo D. Lardone, John R. Jalas, Jaime M. Shamonki, Seema B. Plaisier, Peter A. Sieling, Delphine J. Lee, Marian S. Navarrete
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Oncotarget
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Oncotarget
// Ricardo D. Lardone 1 , Seema B. Plaisier 1 , Marian S. Navarrete 1 , Jaime M. Shamonki 2 , John R. Jalas 3 , Peter A. Sieling 1, * , Delphine J. Lee 1, * 1 Department of Translational Immunology, Dirks/Dougherty Laboratory for Cancer Research, Joh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac7a6945eb6ffaf3b0988c1834219935
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=7361&path[]=21094
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=7361&path[]=21094
Autor:
Michael Weitz, Vanessa Wong, John R. Jalas, Daniel F. Kelly, Samuel J. Klempner, Sai-Hong Ignatius Ou, Oliver Quines, Michele C. Azada
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 96
Alectinib is a second generation ALK inhibitor that has significant clinical activity in central nervous system (CNS) metastases in anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC). Pseudoprogression (PsP) due to radiati
Autor:
Devin C. Flaherty, John R. Jalas, Simon Lavotshkin, Daniel D. Kirchoff, Anton J. Bilchik, Myung Sim, Delphine J. Lee, Hitoe Torisu-Itakura
Publikováno v:
Journal of the American College of Surgeons. 223(1)
Background Retrospective data indicate that immunoprofiling of T cell markers can be prognostic in colon cancer. Prospective T cell immunoprofiling of colon cancer has not been well defined for patients whose lymph nodes are ultrastaged. Study Design